SCYNEXIS Inc. Watch

from 10-Q 3 pages Scynexis Non-Employee Director Compensation Policy Revised April 2024

from 10-Q 18 pages Employment Agreement

from 10-K 13 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential

from 10-K 3 pages Scynexis Non-Employee Director Compensation Policy Revised December 2023; Effective January 1, 2024

from 10-Q 3 pages Third Amendment to Termination and License Agreement

from 10-Q 4 pages Second Amendment to Termination and License Agreement

from 10-Q 2 pages December 3, 2014 By:___/S/ Iain Dukes 12/11/14 Name:___iain Dukes Title:___svp, Research Science

from 10-Q 8 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Redacted Pursuant to Item 601(a)(6) of Regulation S-K

from 10-Q 9 pages October 20, 2022 Christine Rose Coyne

from 10-Q 129 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential. Exclusive License Agreement by and Between Scynexis, Inc. and Glaxosmithkline Intellectual Property (No. 3) Limited Dated as of March 30, 2023

from 10-K 17 pages Employment Agreement

from 10-K 18 pages Employment Agreement

from 10-K 7 pages October 20th, 2022 1. Separation. Your Last Day of Work With the Company and Your Employment Termination Date Will Be December 31, 2022 (The “Separation Date”). 2. Accrued Salary and Paid Time Off. by the Date Required by Applicable Law, the Company Will Pay You All Accrued Salary and All Accrued and Unused Vacation Earned Through the Separation Date, Subject to Standard Payroll Deductions and Withholdings. You Are Entitled to This Payment by Law. 3. Separation Benefits. Although the Company Has No Obligation to Do So, if You Timely Sign This Agreement, Allow It to Become Effective, and Comply With Your Obligations Under It (Collectively, the “Separation Preconditions”), Then

from 10-Q 11 pages Scynexis, Inc. Restricted Stock Unit Award Grant Notice 2015 Inducement Award Plan

from 10-Q 27 pages Scynexis, Inc. 2015 Inducement Award Plan Adopted: March 26, 2015 Amended: June 9, 2019 Adjusted for Reverse Stock Split: July 17, 2020 Further Amended: April 30, 2021 Further Amended: October 18, 2022

from 10-Q 1 page Scynexis Non-Employee Director Compensation Policy Revised June 2022

from 10-Q 17 pages Employment Agreement

from 10-K/A 1 page Scynexis Non-Employee Director Compensation Policy Revised January 2022

from 8-K 10 pages 2014 Scynexis, Inc. Restricted Stock Unit Award Grant Notice 2014 Equity Incentive Plan

from 10-Q 1 page Scynexis Non-Employee Director Compensation Policy Revised June 2021